Erratum to: Which is the best aromatase inhibitor for postmenopausal breast cancer?

被引：0
|
作者：
机构：
来源：
Drugs & Therapy Perspectives | 2001年 / 17卷 / 6期
关键词：
D O I：
10.2165/00042310-200117060-00007
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：15 / 15
相关论文
共 50 条
  • [41] The effect of exercise training on endothelial function in postmenopausal women with breast cancer under aromatase inhibitor therapy
    Barbara, Mayr
    Bernhard, Reich
    Richard, Greil
    Josef, Niebauer
    CANCER MEDICINE, 2022, 11 (24): : 4946 - 4953
  • [42] Auricular point acupressure to manage aromatase inhibitor-induced arthralgia in postmenopausal breast cancer survivors
    Yeh, C.
    Lin, W.
    Wood, L.
    Bovbjerg, D.
    van Londen, G.
    JOURNAL OF PAIN, 2016, 17 (04): : S114 - S114
  • [43] Additive antitumor effect of aromatase inhibitor letrozole and antiestrogen fulvestrant in a postmenopausal breast cancer model.
    Jelovac, D
    Macedo, L
    Goloubeva, OG
    Handratta, V
    Brodie, A
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S37 - S38
  • [44] Aromatase inhibitor-associated bone loss in breast cancer patients is distinct from postmenopausal osteoporosis
    Hadji, Peyman
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2009, 69 (01) : 73 - 82
  • [45] Impact of chemotherapy on symptoms and symptom clusters in postmenopausal women with breast cancer prior to aromatase inhibitor therapy
    Li, Hongjin
    Sereika, Susan M.
    Marsland, Anna L.
    Conley, Yvette P.
    Bender, Catherine M.
    JOURNAL OF CLINICAL NURSING, 2019, 28 (23-24) : 4560 - 4571
  • [46] Clinical dosage determination of a new aromatase inhibitor, anastrozole, in postmenopausal Japanese women with advanced breast cancer
    Nomura, Y
    Koyama, H
    Ohashi, Y
    Watanabe, H
    CLINICAL DRUG INVESTIGATION, 2000, 20 (05) : 357 - 369
  • [47] Letrozole (CGS 20267), a new oral aromatase inhibitor for the treatment of advanced breast cancer in postmenopausal patients
    Trunet, PF
    Bhatnagar, AS
    Chaudri, HA
    Hornberger, U
    ACTA ONCOLOGICA, 1996, 35 (05) : 15 - 18
  • [48] Impact of aromatase inhibitor treatment on vertebral morphology and bone mineral density in postmenopausal women with breast cancer
    Villa, Paola
    Lassandro, Anna P.
    Amar, Inbal D.
    Vacca, Lorenzo
    Moruzzi, Maria C.
    Ferrandina, Gabriella
    Terribile, Daniela
    Masetti, Riccardo
    Scambia, Giovanni
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2016, 23 (01): : 33 - 39
  • [49] Higher than expected estradiol levels in aromatase inhibitor-treated, postmenopausal breast cancer patients
    Kallak, T. Kunovac
    Baumgart, J.
    Evers, A. Stavreus
    Poromaa, I. Sundstrom
    Moby, L.
    Kask, K.
    Norjavaara, E.
    Kushnir, M. M.
    Bergquist, J.
    Nilsson, K.
    CLIMACTERIC, 2012, 15 (05) : 473 - 480
  • [50] Quality of life and psychological functioning in postmenopausal women undergoing aromatase inhibitor treatment for early breast cancer
    Martino, Gabriella
    Catalano, Antonino
    Agostino, Rita Maria
    Bellone, Federica
    Morabito, Nunziata
    Lasco, Carmen Giulia
    Vicario, Carmelo Mario
    Schwarz, Peter
    Feldt-Rasmussen, Ulla
    PLOS ONE, 2020, 15 (03):
12345